Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Urinary Bladder Neoplasms × Mycobacterium w vaccine × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1 Hormone Refractory Prostate Cancer 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Gemcitabine 72 Cisplatin 51 pembrolizumab 24 Paclitaxel 20 Cystectomy 19 Carboplatin 18 durvalumab 17 Nivolumab 17 Docetaxel 17 atezolizumab 14 Specimen Handling 13 Radiotherapy 13 Magnetic Resonance Spectroscopy 13 avelumab 11 Mitomycin 11 Fluorouracil 11 Sunitinib 10 Doxorubicin 10 Methotrexate 9 Vinblastine 8 Filgrastim 7 Ipilimumab 6 BCG Vaccine 6 Standard of Care 5 Sorafenib 5 Radiation 5 Platinum 5 Immunoglobulin G 5 Erlotinib Hydrochloride 5 Disulfides 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00694915 2021-08-17

STCC

Cadila Pharnmaceuticals

Phase 2 Completed

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡